Telomir Pharmaceuticals, Inc. (TELO) stock
TELONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.49−0.01 (-1.96%)
Close on Nov 13, 2026Market cap $33.74MP/E –Yield –
Telomir Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Telomir Pharmaceuticals's cash was $4.52M at Sep 30, 2026. For fiscal 2025 it was $7.29M, up 475.5% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.29M | +475.5% |
| FY2024 | Dec 31, 2024 | $1.27M | +102753.9% |
| FY2023 | Dec 31, 2023 | $1.23K | -13.2% |
| FY2022 | Dec 31, 2022 | $1.42K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $4.52M | -38.4% |
| Q2 FY2026 | Jun 30, 2026 | $5.17M | +585.4% |
| Q1 FY2026 | Mar 31, 2026 | $5.56M | +1279.8% |
| Q4 FY2025 | Dec 31, 2025 | $7.29M | +475.5% |
| Q3 FY2025 | Sep 30, 2025 | $7.33M | +778.1% |
| Q2 FY2025 | Jun 30, 2025 | $754.32K | -60.0% |
| Q1 FY2025 | Mar 31, 2025 | $403.00K | -87.7% |
| Q4 FY2024 | Dec 31, 2024 | $1.27M | +102753.9% |
| Q3 FY2024 | Sep 30, 2024 | $834.64K | +58718.7% |
| Q2 FY2024 | Jun 30, 2024 | $1.88M | – |
| Q1 FY2024 | Mar 31, 2024 | $3.27M | – |
| Q4 FY2023 | Dec 31, 2023 | $1.23K | – |
| Q4 FY2022 | Dec 31, 2022 | $1.42K | – |
See a number that looks wrong?